MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617097110 A) filed by Bharat Serums And Vaccines Ltd. on August 11, 2026, for Purification Process And Formulation Of Recombinant Anti Rhd Monoclonal Antibodies.
Inventors include Gavasane, Mahesh; Gupte, Pranav; Bhise, Lilesh; Bhabal, Tushar; Kambli, Aditee; and Banerjee, Abir.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to an improved purification process for isolating anti- Rhesus D monoclonal antibodies and their antigen-binding fragments. The improved process involves a series of purification techniques, including affinity chromatography, low pH inactivation, anion exchange and cation exchange chromatography, virus/nanofiltration, ultrafiltration and the like. The present invention also encompasses a stable formulation for the purified antibodies or fragments with improved shelf life and performance of the final product.
Disclaimer: Curated by HT Syndication.
